| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |